Riik: Suurbritannia
keel: inglise
Allikas: VMD (Veterinary Medicines Directorate)
Flunixin
Bimeda Animal Health Limited
QM01AG90
Flunixin
Oral paste
POM-V - Prescription Only Medicine – Veterinarian
Horses
Anti Inflammatory NSAID
Authorized
2018-11-01
Issued: November 2018 AN: 01382/2017 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cronyxin 50 mg/g Oral paste for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: 1 gram of paste contains: flunixin 50,0 mg (as flunixin meglumine) 83,0 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral paste White to off-white paste 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of acute inflammatory musculoskeletal disorders in horses 4.3 CONTRAINDICATIONS Do not exceed the stated dose or duration of treatment. Do not administer other NSAIDs or glucocorticosteroids concurrently or within 24 hours of each other. Do not use in animals suffering from cardiac, hepatic or renal disease. Do not use in animals suspected of having gastrointestinal ulceration or bleeding. Do not use in case of hypersensitivity to the active substance or to any of the excipients. Do not use in dehydrated or hypovolaemic animals, except in the case of endotoxaemia or septic shock, as there is a potential risk of increased renal toxicity. Do not use in animals suffering from chronic musculoskeletal disorders. See also section 4.7. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Issued: November 2018 AN: 01382/2017 Page 2 of 5 Use of the veterinary medicinal product may lead to temporary relief due to its ameliorating effects on inflammatory signs. This may appear as effective treatment of the underlying disease. The cause of the underlying inflammatory condition should be determined and treated with appropriate concomitant therapy. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Animals should be rested and a sufficient supply of drinking water has to be ensured during the course of treatment with the veterinary medicinal product. Use in any animal less than 6 weeks of age or in aged animals may involve additional risk. Special precautions to be taken by the person administerin Lugege kogu dokumenti